31 Stocks Moving In Monday's Mid-Day Session

Gainers

• Verona Pharma plc VRNA shares jumped 44.4 percent to $23.3999 after the company disclosed positive top-line data from Phase 2b clinical trial of RPL554 for the maintenance treatment of chronic obstructive pulmonary disease.
• Finish Line, Inc. FINL shares climbed 29.7 percent to $13.685 as the company agreed to sell itself to Europe-based JD Sports Fashion in a deal which values the company at $558 million.
• Ability Inc. ABIL shares rose 22.8 percent to $4.31.
• Cocrystal Pharma, Inc. COCP shares jumped 18.8 percent to $6.00.
• USG Corporation USG gained 17 percent to $39.20after the building-materials manufacturer received a takeover offer from Germany's Knauf KG for $42 per share.
• Akers Biosciences, Inc. AKER shares gained 16.6 percent to $0.9296 after the company disclosed that it has signed US distribution agreement with Diagnostica Stago for the sale of a Heparin test in the US.
• B.O.S Better Online Solutions Ltd. BOSC shares gained 11 percent to $2.2859 following Q4 results. Better Online Solutions reported Q4 earnings of $0.10 per share on sales of $7.9 million.
• Legacy Reserves LP LGCY rose 10.1 percent to $4.92. Legacy Reserves LP reported the execution of definitive documentation to effectuate its corporate transition to Legacy Reserves Inc.
• Precipio, Inc. PRPO gained 10 percent to $0.58820 after the company disclosed a lab services agreement with CORE Diagnotics to enter the Indian market.
• Gaia, Inc. GAIA shares rose 10 percent to $17.10. B. Riley initiated coverage on Gaia with a Buy rating and a $23.00 price target.
• JAKKS Pacific, Inc. JAKK surged 9.9 percent to $2.2527 as the company disclosed that it is working with Bank of America regarding a Jan. 25th proposal from Hong Kong Meisheng Cultural Co. to acquire a 51 percent stake in the company.
• Travelport Worldwide Limited TVPT rose 8.8 percent to $15.62.
• KBS Fashion Group Limited KBSF gained 8.3 percent to $6.50.
• Xinyuan Real Estate Co., Ltd. XIN rose 8.2 percent to $5.692 after the company reported a cross-industry strategic cooperation agreement with Shenzhen Tencent Computer Systems Company Limited.
• ESSA Pharma Inc. EPIX shares surged 7.7 percent to $0.21. H.C. Wainwright initiated coverage on ESSA Pharma with a Buy rating and a $0.70 price target.
• Belden Inc. BDC gained 6.9 percent to $68.97. SunTrust Robinson Humphrey upgraded Belden from Hold to Buy.
• Microsoft Corporation MSFT rose 6 percent to $92.39. Microsoft disclosed a partnership with SPIN Analytics to accelerate access to SPIN Analytics' exclusive RISKROBOT® AI-engine.

Check out these big penny stock gainers and losers

Losers

• Protagonist Therapeutics, Inc. PTGX shares tumbled 56.4 percent to $8.90 as the company disclosed that it has discontinued Phase 2b PROPEL trial of PTG-100 for the treatment of ulcerative colitis following interim analysis.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN dropped 29.4 percent to $17.48. Biohaven disclosed that it has achieved both co-primary regulatory endpoints in its two pivotal Phase 3 trials of rimegepant for the acute treatment of migraine.
• Bonso Electronics International Inc. BNSO shares fell 22.6 percent to $3.02 following half year results. Bonso late Friday reported earnings of $0.14 per share for the six-month period ended September 30, 2017, down from $0.21 in the year-ago period.
• Cesca Therapeutics Inc. KOOL fell 17.5 percent to $2.21 after the company reported a registered direct offering to sell 610,000 shares at $2.27 per share.
• New Age Beverages Corporation NBEV dipped 15.1 percent to $2.30 after declining 5.90 percent on Friday.
• Zosano Pharma Corporation ZSAN shares fell 11.8 percent to $14.15 after dropping 4.97 percent on Friday.
• China Auto Logistics Inc. CALI shares dropped 11.3 percent to $4.6115.
• iFresh Inc. IFMK shares dipped 10.5 percent to $8.25.
• PLx Pharma Inc. PLXP fell 10.4 percent to $4.75. Janney Capital downgraded PLx Pharma from Buy to Neutral.
• Boston Omaha Corporation BOMN shares dropped 10.2 percent to $23.35.
• Athenex, Inc. ATNX fell 9.6 percent to $14.63. Athenex reported a Q4 loss of $28.3 million on revenue of $14.9 million.
• Longfin Corp. LFIN shares declined 9.3 percent to $64.50.
• Odonate Therapeutics, Inc. ODT shares fell 8.4 percent to $22.00.
• Compugen Ltd. CGEN shares dropped 6.2 percent to $3.845. Compugen named Dr. Henry Adewoye as Chief Medical Officer, effective immediately.